ANITA PUNJABI BAJPAI: Open Payments
NPI 1891922662 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$582 in 31 payments from 15 companies in 2025. Trend: 2023 $322 · 2024 $256 · 2025 $582
Food & beverage: $582
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $207 |
| Abbott Laboratories | 3 | $71 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Novo Nordisk Inc | 2 | $36 |
| Amgen Inc. | 2 | $31 |
| Corcept Therapeutics | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
Products named: ELIQUIS, PREVNAR 20, FREESTYLE LIBRE 3, SHINGRIX, REXULTI, Korlym, JASCAYD, GEMTESA.
Industry payments across TX — which companies pay providers there.
